FUS

FUS RNA binding protein, the group of Zinc fingers RANBP2-type |RNA binding motif containing|Heterogeneous nuclear ribonucleoproteins

Basic information

Region (hg38): 16:31180138-31196963

Previous symbols: [ "ALS6" ]

Links

ENSG00000089280NCBI:2521OMIM:137070HGNC:4010Uniprot:P35637AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • amyotrophic lateral sclerosis type 6 (Strong), mode of inheritance: AD
  • amyotrophic lateral sclerosis (Definitive), mode of inheritance: AD
  • amyotrophic lateral sclerosis (Supportive), mode of inheritance: AD
  • juvenile amyotrophic lateral sclerosis (Supportive), mode of inheritance: AR
  • tremor, hereditary essential, 4 (Limited), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 6 (Strong), mode of inheritance: AD
  • tremor, hereditary essential, 4 (Limited), mode of inheritance: Unknown
  • amyotrophic lateral sclerosis type 6 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; Tremor, hereditary essential, 4AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic12840784; 12858291; 19741216; 19251627; 19741215; 19251628; 19861302; 20385912; 20577002; 20660363; 20668259; 22863194; 22980027; 22999566; 23046859

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FUS gene.

  • Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 (10 variants)
  • not provided (10 variants)
  • Amyotrophic lateral sclerosis type 6 (7 variants)
  • Tremor, hereditary essential, 4;Amyotrophic lateral sclerosis type 6 (6 variants)
  • Juvenile amyotrophic lateral sclerosis (2 variants)
  • FUS-related disorder (2 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FUS gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
72
clinvar
4
clinvar
77
missense
8
clinvar
7
clinvar
113
clinvar
9
clinvar
137
nonsense
3
clinvar
1
clinvar
4
start loss
0
frameshift
12
clinvar
12
inframe indel
16
clinvar
5
clinvar
1
clinvar
22
splice donor/acceptor (+/-2bp)
2
clinvar
2
clinvar
3
clinvar
1
clinvar
8
splice region
10
16
1
27
non coding
17
clinvar
63
clinvar
21
clinvar
101
Total 25 10 150 150 26

Highest pathogenic variant AF is 0.0000136

Variants in FUS

This is a list of pathogenic ClinVar variants found in the FUS region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-31180161-A-G Amyotrophic lateral sclerosis type 6 Benign (Jul 03, 2018)318979
16-31180162-C-T Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)318980
16-31180164-C-T Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)885383
16-31180166-G-A Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)885384
16-31180166-G-T Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)318981
16-31180167-C-G Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)885385
16-31180168-G-A Amyotrophic lateral sclerosis type 6 Benign/Likely benign (Sep 08, 2020)887473
16-31180171-G-A Likely benign (Nov 01, 2021)1335212
16-31180176-A-G Amyotrophic lateral sclerosis type 6 Benign/Likely benign (Jul 13, 2019)318982
16-31180200-C-G Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 12, 2018)887474
16-31180209-G-C Uncertain significance (Feb 01, 2024)3025729
16-31180210-C-G FUS-related disorder Likely benign (Dec 18, 2019)3047979
16-31180220-C-T FUS-related disorder Likely benign (Dec 15, 2021)3029985
16-31180236-GGGC-G Dystonic disorder;Myoclonus • Amyotrophic lateral sclerosis type 6 Uncertain significance (Oct 19, 2018)374092
16-31182389-C-G Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 • FUS-related disorder Likely benign (Nov 02, 2022)2069851
16-31182415-A-G not specified Uncertain significance (Jun 26, 2017)447356
16-31182441-C-T Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 Likely benign (Apr 22, 2023)2945750
16-31182495-G-A Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 Uncertain significance (Oct 18, 2023)2953046
16-31182501-C-T Amyotrophic lateral sclerosis type 6 Uncertain significance (Jan 13, 2018)887475
16-31182502-C-G Tremor, hereditary essential, 4;Amyotrophic lateral sclerosis type 6 Likely benign (Sep 01, 2021)1601917
16-31182514-T-A Amyotrophic lateral sclerosis type 6 Uncertain significance (Mar 16, 2018)887476
16-31182515-A-G FUS-related disorder Uncertain significance (Oct 03, 2022)2628761
16-31182521-C-T Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 • Inborn genetic diseases • FUS-related disorder Likely benign (Nov 04, 2022)1530335
16-31182526-C-A Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 Likely benign (Sep 08, 2023)1113414
16-31182526-C-T Amyotrophic lateral sclerosis type 6 • Amyotrophic lateral sclerosis type 6;Tremor, hereditary essential, 4 • FUS-related disorder Uncertain significance (Jul 30, 2020)887477

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FUSprotein_codingprotein_codingENST00000254108 1511697
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.000695125728051257330.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.212173300.6580.00002073400
Missense in Polyphen2863.6840.43967648
Synonymous-2.131471181.250.000007451027
Loss of Function5.16438.60.1040.00000228381

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005910.0000591
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001770.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single- stranded DNAs and D-loop formation in superhelical double-stranded DNA. May play a role in maintenance of genomic integrity.;
Disease
DISEASE: Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.; DISEASE: Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. {ECO:0000269|PubMed:8187069}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.; DISEASE: Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201, ECO:0000269|PubMed:27604643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Transcriptional misregulation in cancer - Homo sapiens (human);mRNA Processing;Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA (Consensus)

Recessive Scores

pRec
0.491

Intolerance Scores

loftool
0.00503
rvis_EVS
-1
rvis_percentile_EVS
8.32

Haploinsufficiency Scores

pHI
0.426
hipred
Y
hipred_score
0.775
ghis
0.679

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.856

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fus
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
fus
Affected structure
CaP motoneuron
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;cellular response to calcium ion;positive regulation of nucleic acid-templated transcription
Cellular component
nucleus;nucleoplasm;polysome;perikaryon;dendritic spine head;perinuclear region of cytoplasm
Molecular function
DNA binding;transcription coactivator activity;RNA binding;protein binding;estrogen receptor binding;myosin V binding;ionotropic glutamate receptor binding;identical protein binding;metal ion binding;retinoid X receptor binding;thyroid hormone receptor binding